litlas
Log inCreate account

Lynn Morris

Active 1981–2025

138
Papers
23,200
Citations
86
h-index
136
i10-index

Citations

Citations per year for Lynn Morris1982: 4 citations1983: 14 citations1984: 13 citations1985: 9 citations1986: 6 citations1987: 12 citations1988: 9 citations1989: 6 citations1990: 6 citations1991: 5 citations1992: 12 citations1993: 19 citations1994: 23 citations1995: 26 citations1996: 17 citations1997: 12 citations1998: 20 citations1999: 13 citations2000: 22 citations2001: 29 citations2002: 27 citations2003: 40 citations2004: 40 citations2005: 47 citations2006: 76 citations2007: 80 citations2008: 83 citations2009: 183 citations2010: 170 citations2011: 283 citations2012: 280 citations2013: 223 citations2014: 217 citations2015: 296 citations2016: 289 citations2017: 284 citations2018: 209 citations2019: 641 citations2020: 571 citations2021: 752 citations2022: 407 citations2023: 288 citations2024: 503 citations2025: 255 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,562 citing papers, 37.7% of this breakdownUnited Kingdom: 555 citing papers, 8.2% of this breakdownSouth Africa: 529 citing papers, 7.8% of this breakdownNetherlands: 237 citing papers, 3.5% of this breakdownFrance: 218 citing papers, 3.2% of this breakdownChina: 216 citing papers, 3.2% of this breakdownCanada: 206 citing papers, 3% of this breakdownGermany: 192 citing papers, 2.8% of this breakdownSwitzerland: 177 citing papers, 2.6% of this breakdownAustralia: 141 citing papers, 2.1% of this breakdownItaly: 108 citing papers, 1.6% of this breakdownBelgium: 101 citing papers, 1.5% of this breakdown
0%37.7%Other 22.8%

Institutions

Fields

  • Immunology and Microbiology44.5%
  • Medicine42.9%
  • Biochemistry, Genetics and Molecular Biology7.7%
  • Agricultural and Biological Sciences0.7%
  • Neuroscience0.7%
  • Social Sciences0.7%
  • Other2.8%

Topics

  • HIV Research and Treatment16.3%
  • HIV/AIDS Research and Interventions7.3%
  • HIV/AIDS drug development and treatment7.3%
  • Immune Cell Function and Interaction5.8%
  • Monoclonal and Polyclonal Antibodies Research5.5%
  • T-cell and B-cell Immunology3.7%
  • Other54.1%

Coauthors

All papers

Open in search
  1. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Authors: Lawrence Corey, Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna, Srilatha Edupuganti, Nyaradzo Mgodi, Allan C. deCamp, Erika Rudnicki, Yunda Huang, Pedro Gonzáles, Robinson Cabello, Catherine Orrell, Javier R. Lama, Fatima Laher, Erica Lazarus, Jorge Sánchez, Ian Frank, Juan Hinojosa, Magdalena E. Sobieszczyk, Kyle Marshall, Pamela Mukwekwerere, Joseph Makhema, Lindsey R. Baden, James I. Mullins, Carolyn Williamson, John Hural, M. Juliana McElrath, Carter Bentley, Simbarashe Takuva, Margarita M. Gomez Lorenzo, David Burns, Nicole Espy, April K. Randhawa, Nidhi Kochar, Estelle Piwowar‐Manning, Deborah Donnell, Nirupama Sista, P. Andrew, James G. Kublin, Glenda Gray, Julie E. Ledgerwood, John R. Mascola, Myron S. Cohen - New England Journal of Medicine 2021 cited by 539

  2. High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity

    Authors: Ian Setliff, Andrea R. Shiakolas, Kelsey A. Pilewski, Amyn A. Murji, Rutendo E. Mapengo, Katarzyna Janowska, Simone I. Richardson, Charissa Oosthuysen, Nagarajan Raju, Larance Ronsard, Masaru Kanekiyo, Juliana S. Qin, Kevin J. Kramer, Allison R. Greenplate, Wyatt J. McDonnell, Barney S. Graham, Mark Connors, Daniel Lingwood, Priyamvada Acharya, Lynn Morris, Ivelin S. Georgiev - Cell 2019 cited by 343

  3. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

    Authors: Peter B. Gilbert, Yunda Huang, Allan C. deCamp, Shelly Karuna, Yuanyuan Zhang, Craig A. Magaret, Elena E. Giorgi, Bette Korber, Paul T. Edlefsen, Raabya Rossenkhan, Michal Juraska, Erika Rudnicki, Nidhi Kochar, Ying Huang, Lindsay N. Carpp, Dan H. Barouch, Nonhlanhla N. Mkhize, Tandile Hermanus, Prudence Kgagudi, Valerie Bekker, Haajira Kaldine, Rutendo E. Mapengo, Amanda Eaton, Elize Domin, Carley West, Wenhong Feng, Haili Tang, Kelly E. Seaton, Jack Heptinstall, Caroline Brackett, Kelvin Chiong, Georgia D. Tomaras, P. Andrew, Bryan T. Mayer, Daniel B. Reeves, Magdalena E. Sobieszczyk, Nigel Garrett, Jorge Sánchez, Cynthia L. Gay, Joseph Makhema, Carolyn Williamson, James I. Mullins, John Hural, Myron S. Cohen, Lawrence Corey, David C. Montefiori, Lynn Morris - Nature Medicine 2022 cited by 126

  4. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

    Authors: Nicole A. Doria‐Rose, Chaim A. Schramm, Jason Gorman, Penny L. Moore, Jinal N. Bhiman, Brandon J. DeKosky, Michael J. Ernandes, Ivelin S. Georgiev, Helen J. Kim, Marie Pancera, Ryan P. Staupe, Han Altae-Tran, Robert T. Bailer, Ema T. Crooks, Albert Cupo, Aliaksandr Druz, Nigel Garrett, Kam Hon Hoi, Rui Kong, Mark K. Louder, Nancy S. Longo, Krisha McKee, Molati Nonyane, Sijy O’Dell, Ryan S. Roark, Rebecca S. Rudicell, Stephen D. Schmidt, Daniel J. Sheward, Cinque Soto, Constantinos Kurt Wibmer, Yongping Yang, Zhenhai Zhang, NISC Comparative Sequencing, James C. Mullikin, James Μ. Binley, Rogier W. Sanders, Ian A. Wilson, John P. Moore, Andrew C. Ward, George Georgiou, Carolyn Williamson, Salim S. Abdool Karim, Lynn Morris, Peter D. Kwong, Lawrence Shapiro, John R. Mascola - Nature 2014 cited by 756

  5. Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    Authors: Marie Pancera, Tongqing Zhou, Aliaksandr Druz, Ivelin S. Georgiev, Cinque S. Soto, Jason Gorman, Jinghe Huang, Priyamvada Acharya, Gwo-Yu Chuang, Gilad Ofek, Guillaume B. E. Stewart-Jones, Jonathan Stuckey, Robert T. Bailer, M. Gordon Joyce, Mark K. Louder, Nancy Tumba, Yongping Yang, Baoshan Zhang, Myron S. Cohen, Barton F. Haynes, John R. Mascola, Lynn Morris, James B. Munro, Scott C. Blanchard, Walther Mothes, Mark Connors, Peter D. Kwong - Nature, Nat. 2014 cited by 779

  6. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

    Authors: Nicole A. Doria‐Rose, Jinal N. Bhiman, Ryan S. Roark, Chaim A. Schramm, Jason Gorman, Gwo‐Yu Chuang, Marie Pancera, Evan M. Cale, Michael J. Ernandes, Mark K. Louder, Mangaiarkarasi Asokan, Robert T. Bailer, Aliaksandr Druz, Isabella Fraschilla, Nigel Garrett, Marissa Jarosinski, Rebecca M. Lynch, Krisha McKee, Sijy O’Dell, Amarendra Pegu, Stephen D. Schmidt, Ryan P. Staupe, Matthew S. Sutton, Keyun Wang, Constantinos Kurt Wibmer, Barton F. Haynes, Salim S. Abdool Karim, Lawrence Shapiro, Peter D. Kwong, Penny L. Moore, Lynn Morris, John R. Mascola - Journal of Virology 2015 cited by 261

  7. Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies

    Authors: Mattia Bonsignori, Edward F. Kreider, Daniela Fera, Robert Meyerhoff, Todd Bradley, Kevin Wiehe, S. Munir Alam, Baptiste Aussedat, William E. Walkowicz, Kwan‐Ki Hwang, Kevin O. Saunders, Ruijun Zhang, Morgan A. Gladden, Anthony Monroe, Amit Kumar, Shi-Mao Xia, Melissa Cooper, Mark K. Louder, Krisha McKee, Robert T. Bailer, Brendan W. Pier, Claudia A. Jette, Garnett Kelsoe, Wilton B. Williams, Lynn Morris, John C. Kappes, Kshitij Wagh, Gift Kamanga, Myron S. Cohen, Peter Hraber, David C. Montefiori, Ashley M. Trama, Hua‐Xin Liao, Thomas B. Kepler, M. Anthony Moody, Feng Gao, Samuel J. Danishefsky, John R. Mascola, George M. Shaw, Beatrice H. Hahn, Stephen C. Harrison, Bette Korber, Barton F. Haynes - Science Translational Medicine 2017 cited by 290

  8. Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Authors: Georgia D. Tomaras, Nicole L. Yates, Pinghuang Liu, Qin Li, Genevieve G. Fouda, L. L. Chavez, Allan C. deCamp, Robert Parks, Vicki C Ashley, Judith T. Lucas, Myron S. Cohen, Joseph J. Eron, Charles B. Hicks, Hua-Xin Liao, Steven G. Self, Gary Landucci, Donald N. Forthal, Kent J. Weinhold, Brandon F. Keele, Beatrice H. Hahn, Michael Greenberg, Lynn Morris, Salim S. Abdool Karim, William A. Blattner, David C. Montefiori, George M. Shaw, Alan S. Perelson, Barton F. Haynes - Journal of Virology 2008 cited by 624

  9. Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection

    Authors: Kshitij Wagh, Tanmoy Bhattacharya, Carolyn Williamson, Alex Robles, Madeleine Bayne, Garrity Jetta, Michael Rist, Cecilia Rademeyer, Hyejin Yoon, Alan S. Lapedes, Hongmei Gao, Kelli Greene, Mark K. Louder, Rui Kong, Salim S. Abdool Karim, Dennis R. Burton, Dan H. Barouch, Michel C. Nussenzweig, John R. Mascola, Lynn Morris, David C. Montefiori, Bette Korber, Michael S. Seaman - PLoS Pathogens 2016 cited by 200

  10. Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

    Authors: Jason Gorman, Cinque Soto, Max M. Yang, Thaddeus M. Davenport, Miklós Guttman, Robert T. Bailer, Michael Chambers, Gwo‐Yu Chuang, Brandon J. DeKosky, Nicole A. Doria‐Rose, Aliaksandr Druz, Michael J. Ernandes, Ivelin S. Georgiev, Marissa Jarosinski, Michael Joyce, Thomas Lemmin, Sherman S. Leung, Mark K. Louder, Jonathan R. McDaniel, Sandeep Narpala, Marie Pancera, Jonathan Stuckey, Xueling Wu, Yongping Yang, Baoshan Zhang, Tongqing Zhou, NISC Comparative Sequencing Program, James C. Mullikin, Ulrich Baxa, George Georgiou, Adrian B. McDermott, Mattia Bonsignori, Barton F. Haynes, Penny L. Moore, Lynn Morris, Kelly K. Lee, Lawrence Shapiro, John R. Mascola, Peter D. Kwong - Nature Structural & Molecular Biology 2015 cited by 195

  11. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

    Authors: Jason Gorman, Gwo‐Yu Chuang, Yen‐Ting Lai, Chen‐Hsiang Shen, Jeffrey C. Boyington, Aliaksandr Druz, Hui Geng, Mark K. Louder, Krisha McKee, Reda Rawi, Raffaello Verardi, Yongping Yang, Baoshan Zhang, Nicole A. Doria‐Rose, Bob C. Lin, Penny L. Moore, Lynn Morris, Lawrence Shapiro, John R. Mascola, Peter D. Kwong - Cell Reports 2020 cited by 84

  12. Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

    Authors: Nonhlanhla N. Mkhize, Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume, David Matten, Bronwen E. Lambson, Tandile Modise, Prudence Kgagudi, Talita York, Dylan H. Westfall, Elena E. Giorgi, Bette Korber, Colin Anthony, Rutendo E. Mapengo, Valerie Bekker, Elizabeth Domin, Amanda Eaton, Wenjie Deng, Allan C. deCamp, Yunda Huang, Peter B. Gilbert, Asanda Gwashu-Nyangiwe, Ruwayhida Thebus, Nonkululeko Ndabambi, Dieter Mielke, Nyaradzo Mgodi, Shelly Karuna, Srilatha Edupuganti, Michael S. Seaman, Lawrence Corey, Myron S. Cohen, John Hural, M. Juliana McElrath, James I. Mullins, David C. Montefiori, Penny L. Moore, Carolyn Williamson, Lynn Morris - PLoS Pathogens 2023 cited by 56

  13. Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection

    Authors: Ian Setliff, Wyatt J. McDonnell, Nagarajan Raju, Robin Bombardi, Amyn A. Murji, Cathrine Scheepers, Rutendo Ziki, Charissa Mynhardt, Bryan E. Shepherd, Alusha A. Mamchak, Nigel Garrett, Salim S. Abdool Karim, S. Mallal, James E. Crowe, Lynn Morris, Ivelin S. Georgiev - Cell Host & Microbe 2018 cited by 129

  14. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

    Authors: Linda‐Gail Bekker, Zoe Moodie, Nicole Grunenberg, Fatima Laher, Georgia D. Tomaras, Kristen W. Cohen, Mary Allen, Mookho Malahleha, Kathryn Mngadi, Brodie Daniels, Craig Innes, Carter Bentley, Nicole Frahm, Daryl E. Morris, Lynn Morris, Nonhlanhla N. Mkhize, David C. Montefiori, Marcella Sarzotti‐Kelsoe, Shannon Grant, Chenchen Yu, Vijay Mehra, Michael Pensiero, Sanjay Phogat, Carlos A. DiazGranados, Susan W. Barnett, Niranjan Kanesa-thasan, Marguerite Koutsoukos, Nelson L. Michael, Merlin L. Robb, James G. Kublin, Peter B. Gilbert, Lawrence Corey, Glenda Gray, M. Juliana McElrath - The Lancet HIV 2018 cited by 124

  15. The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4 + T Cell Decline and High Viral Load during Acute Infection

    Authors: Elin S. Gray, Maphuti Madiga, Tandile Hermanus, Penny L. Moore, Constantinos Kurt Wibmer, Nancy Tumba, Lise Werner, Koleka Mlisana, Sengeziwe Sibeko, Carolyn Williamson, Salim S. Abdool Karim, Lynn Morris, and the CAPRISA002 Study Team - Journal of Virology 2011 cited by 472

  16. Neutralization tiers of HIV-1

    Authors: David C. Montefiori, Mario Roederer, Lynn Morris, Michael S. Seaman - Current Opinion in HIV and AIDS 2017 cited by 105

  17. Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors

    Authors: Mattia Bonsignori, Kwan-Ki Hwang, Xi Chen, Chun-Yen Tsao, Lynn Morris, Elin S. Gray, Dawn J. Marshall, John A. Crump, Saidi Kapiga, Noel E. Sam, Faruk Sinangil, Marie Pancera, Yang Yongping, Baoshan Zhang, Jiang Zhu, Peter D. Kwong, Sijy O’Dell, John R. Mascola, Lan Wu, Gary J. Nabel, Sanjay Phogat, Michael S. Seaman, John F. Whitesides, M. Anthony Moody, Garnett Kelsoe, Xinzhen Yang, Joseph Sodroski, George M. Shaw, David C. Montefiori, Thomas B. Kepler, Georgia D. Tomaras, S. Munir Alam, Hua-Xin Liao, Barton F. Haynes - Journal of Virology 2011 cited by 439

  18. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    Authors: John Gregson, Michele W. Tang, Nicaise Ndembi, Raph L Hamers, Soo‐Yon Rhee, Vincent C. Marconi, Lameck Diero, Katherine Brooks, Kristof Theys, Tobias Rinke de Wit, Mônica Barcellos Arruda, Fréderico Duarte Garcia, Susana Monge, Huldrych F. Günthard, Christopher J. Hoffmann, Phyllis J. Kanki, N. Kumarasamy, Bernard Kerschberger, Orna Mor, Charlotte Charpentier, Eva Todesco, Casper Rokx, Luuk Gras, Elias K Helvas, Henry Sunpath, Domenico Di Carlo, Antonio Antinori, Massimo Andreoni, Alessandra Latini, Cristina Mussini, Avelin F. Aghokeng, Anders Sönnerborg, Ujjwal Neogi, W. Jeffrey Fessel, Simon Agolory, Chunfu Yang, José Luís Blanco, James Juma, Erasmus Smit, Daniel Schmidt, Christine Watera, Juliet Asio, Wilford Kurungi, Anna Tostevin, Tal El‐Hay, Nathan Clumeck, Dominique Goedhals, Cloete van Vuuren, Philip Armand Bester, Caroline Sabin, Irene Mukui, Maria Mercedes Santoro, Carlo Federico Perno, Gillian Hunt, Lynn Morris, Ricardo Camacho, Túlio de Oliveira, Deenan Pillay, Eugene Schulter, Akio Murakami-Ogasawara, Gustavo Reyes‐Terán, Karla Romero, Santiago Ávila‐Ríos, Sunee Sirivichayakul, Kiat Ruxrungtham, Suwanna Mekprasan, David Dunn, Pontiano Kaleebu, Elliot Raizes, Rami Kantor, Robert W. Shafer, Ravindra K. Gupta - The Lancet Infectious Diseases 2016 cited by 275

  19. Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

    Authors: LaTonya D. Williams, Gilad Ofek, Sebastian Schätzle, Jonathan R. McDaniel, Xiaozhi Lu, Nathan I. Nicely, Liming Wu, Caleb S. Lougheed, Todd Bradley, Mark K. Louder, Krisha McKee, Robert T. Bailer, Sijy O’Dell, Ivelin S. Georgiev, Michael S. Seaman, Robert Parks, Dawn J. Marshall, Kara Anasti, Guang Yang, Xiaoyan Nie, Nancy Tumba, Kevin Wiehe, Kshitij Wagh, Bette Korber, Thomas B. Kepler, S. Munir Alam, Lynn Morris, Gift Kamanga, Myron S. Cohen, Mattia Bonsignori, Shi-Mao Xia, David C. Montefiori, Garnett Kelsoe, Feng Gao, John R. Mascola, M. Anthony Moody, Kevin O. Saunders, Hua-Xin Liao, Georgia D. Tomaras, George Georgiou, Barton F. Haynes - Science Immunology 2017 cited by 159

  20. IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

    Authors: Simone I. Richardson, Bronwen E. Lambson, Andrew R. Crowley, Arman Bashirova, Cathrine Scheepers, Nigel Garrett, Salim S. Abdool Karim, Nonhlanhla N. Mkhize, Mary Carrington, Margaret E. Ackerman, Penny L. Moore, Lynn Morris - PLoS Pathogens 2019 cited by 99

  21. Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

    Authors: Kelly E. Seaton, Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong, Lily Zhang, Nicole L. Yates, Mark Sampson, Erika Rudnicki, Michal Juraska, Allan C. deCamp, Paul T. Edlefsen, James I. Mullins, Carolyn Williamson, Raabya Rossenkhan, Elena E. Giorgi, Avi Kenny, Heather Angier, April K. Randhawa, Joshua A. Weiner, Michelle Rojas, Marcella Sarzotti‐Kelsoe, Lu Zhang, Sheetal Sawant, Margaret E. Ackerman, Adrian B. McDermott, John R. Mascola, John Hural, M J McElrath, P. Andrew, José A. Hidalgo, Jesse N. Clark, Fatima Laher, Catherine Orrell, Ian Frank, Pedro Gonzáles, Srilatha Edupuganti, Nyaradzo Mgodi, Lawrence Corey, Lynn Morris, David C. Montefiori, Myron S. Cohen, Peter B. Gilbert, Georgia D. Tomaras - EBioMedicine 2023 cited by 33

  22. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

    Authors: Quarraisha Abdool Karim, Salim S. Abdool Karim, Janet Frohlich, Anneke Grobler, Cheryl Baxter, Leila E. Mansoor, Ayesha B. M. Kharsany, Sengeziwe Sibeko, Koleka Mlisana, Zaheen Omar, Tanuja N. Gengiah, Silvia Maarschalk, Natasha Arulappan, Mukelisiwe Mlotshwa, Lynn Morris, Douglas Taylor, on behalf of the CAPRISA 004 Trial Group - Science 2010 cited by 2,443

  23. Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial

    Authors: Sharana Mahomed, Nigel Garrett, Edmund V. Capparelli, Farzana Osman, Nonhlanhla N. Mkhize, Ishana Harkoo, Tanuja N. Gengiah, Leila E. Mansoor, Cheryl Baxter, Derseree Archary, Nonhlanhla Yende‐Zuma, Natasha Samsunder, Kevin Carlton, Sandeep Narpala, Adrian B. McDermott, Nicole A. Doria‐Rose, Penny L. Moore, Lynn Morris, Quarraisha Abdool Karim, John R. Mascola, Salim S. Abdool Karim - The Lancet HIV 2023 cited by 40

  24. Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

    Authors: Mina C. Hosseinipour, Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hütter, Gita Ramjee, Modulakgotla Sebe, Lucas Maganga, Michael E. Herce, Allan C. deCamp, Kyle Marshall, One Dintwe, Erica Andersen‐Nissen, Georgia D. Tomaras, Nonhlanhla N. Mkhize, Lynn Morris, Ryan L. Jensen, Maurine D. Miner, Giuseppe Pantaleo, S.-W Ding, Olivier Van Der Meeren, Susan W. Barnett, M. Juliana McElrath, Lawrence Corey, James G. Kublin, HVTN 111 Protocol Team, Nicole Frahm, Barbara Metch, Marguerite Koutsoukos, Stewart Reid, Bupe Sichalwe, Mah Asombang, Christine Namakobo, Sam Mundia, Lumbwe Banda, Joyce Mapanza, Jacinta Shilimi, Emmanuel Kapesa, Abisai Kisinda, Cornelia Lueer, Lilian Njovu, Wiston William, Faith Mlagalila, Elizabeth Ntapara, Willhelmina Olomi, Nnhamo Chiwerengo, Revocatus Kunambi, Bahati Myombe, Rosemary Mwilinga, Neema Mbinda, Joyce Masala, Joseph Mapunda, On Ho, Denelle Reilly, Liz Briesemeister, Marianne Hansen, Jill Zeller, Simbarashe Takuva, Caroline Brackett, Jack Heptinstall, Kelly E. Seaton, David Beaumont, Lu Zhang, Sheetal Sawant, Marcella Sarzotti‐Kelsoe, Tandile Hermanus, Valerie Bekker, Stephen De Rosa, Saleha Omarjee, Stephany Wilcox, Shamiska Rohith, Asiphe Basethi, R Da Costa Noble, Daryl E. Morris - Clinical Infectious Diseases 2020 cited by 35